Korean J Urol.  2009 May;50(5):423-431.

Ureteropelvic Junction Obstruction: What We Know and What We Don't Know

• Lee H
• Han SW

Abstract

PURPOSE: Ureteropelvic junction (UPJ) obstruction is by far the most common cause of pediatric hydronephrosis. The widespread use of antenatal ultrasonography and modern imaging techniques has resulted in earlier and more common diagnosis of hydronephrosis. However, compared with this increased earlier detection, little has changed regarding the management of hydronephrosis. Through this review, we wish to provide an overview of the studies done to date and search for areas that warrant further study.
MATERIALS AND METHODS
Through PubMed, we reviewed the literature on the subject of UPJ obstruction in the pediatric population. We also present data from our institution regarding recent trends in the evaluation and treatment of UPJ obstructions.
RESULTS
In addition to conventional imaging studies, attempts are being made at making use of biochemical parameters (e.g., beta2 m, N-acetyl-beta-D-glucosaminidase [NAG], transforming growth factor [TGF]-beta, etc.) as not only indicators of intervention but also prognostic factors during follow-up. Although we routinely use radionuclide imaging to evaluate renal function, a more accurate novel tool that can represent true renal function is needed. With the development in the field of laparoscopic and minimally invasive surgery, the role of laparoscopy and robot-assisted laparoscopic pyeloplasty is expanding, even in the pediatric population. However, relatively little is known about the factors that might be associated with postoperative outcomes.
CONCLUSIONS
Not missing the optimal time for surgical intervention is as important as avoiding unnecessary surgery. Continuous development and refining of surgical skills for UPJ obstruction repair are requisites for (pediatric) urologists as is in-depth basic research of the disease.

Keyword

Ureteral obstruction; Radionuclide imaging; Laparoscopy; Prognosis

MeSH Terms

Acetylglucosaminidase
Follow-Up Studies
Hydronephrosis
Laparoscopy
Prognosis
Transforming Growth Factors
Unnecessary Procedures
Ureteral Obstruction
Acetylglucosaminidase
Transforming Growth Factors

Figure

• 

  Fig. 1 The type of ureteral narrowing. (A) Narrowing of the UPJ only. (B) Multiple ureteral narrowing. (C, D) Hypoplastic ureters (Adopted from Kim et al. Korean J Urol 2003;44:550-5). UPJ: ureteropelvic junction.

Reference

1. Capello SA, Kogan BA, Giorgi LJ Jr, Kaufman RP Jr. Prenatal ultrasound has led to earlier detection and repair of ureteropelvic junction obstruction. J Urol. 2005. 174:1425–1428.

2. Wiener JS, Emmert GK, Mesrobian HG, Whitehurst AW, Smith LR, King LR. Are modern imaging techniques over diagnosing ureteropelvic junction obstruction? J Urol. 1995. 154:659–661.

3. Carr MC, El-Ghoneimi A. Campbell MF, Wein AJ, Kavoussi LR, editors. Anomalies and surgery of the ureteropelvic junction in children. Campbell-Walsh urology. 2007. 9th ed. Philadelphia: Saunders Elsevier;3359.

4. Ruano-Gil D, Coca-Payeras A, Tejedo-Mateu A. Obstruction and normal recanalization of the ureter in the human embryo. Its relation to congenital ureteric obstruction. Eur Urol. 1975. 1:287–293.

5. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature. 1993. 362:65–67.

6. Furness PD 3rd, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol. 1999. 162:1033–1036.

7. Maizels M, Stephens FD. Valves of the ureter as a cause of primary obstruction of the ureter: anatomic, embryologic and clinical aspects. J Urol. 1980. 123:742–747.

8. Murnaghan GF. The dynamics of the renal pelvis and ureter with reference to congenital hydronephrosis. Br J Urol. 1958. 30:321–329.

9. Hosgor M, Karaca I, Ulukus C, Ozer E, Ozkara E, Sam B, et al. Structural changes of smooth muscle in congenital ureteropelvic junction obstruction. J Pediatr Surg. 2005. 40:1632–1636.

10. Solari V, Piotrowska AP, Puri P. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction. J Urol. 2003. 170:2420–2422.

11. Stephens FD. Ureterovascular hydronephrosis and the "aberrant" renal vessels. J Urol. 1982. 128:984–987.

12. Sampaio FJ. Vascular anatomy at the ureteropelvic junction. Urol Clin North Am. 1998. 25:251–258.

13. Ross JH, Kay R, Knipper NS, Streem SB. The absence of crossing vessels in association with ureteropelvic junction obstruction detected by prenatal ultrasonography. J Urol. 1998. 160:973–975.

14. Ross JH, Kay R. Ureteropelvic junction obstruction in anomalous kidneys. Urol Clin North Am. 1998. 25:219–225.

15. Klahr S. Pathophysiology of obstructive nephropathy. Kidney Int. 1983. 23:414–426.

16. Stock JA, Krous HF, Heffernan J, Packer M, Kaplan GW. Correlation of renal biopsy and radionuclide renal scan differential function in patients with unilateral ureteropelvic junction obstruction. J Urol. 1995. 154:716–718.

17. Josephson S. Experimental obstructive hydronephrosis in newborn rats. III. Long-term effects on renal function. J Urol. 1983. 129:396–400.

18. Josephson S, Ericson AC, Sjoquist M. Experimental obstructive hydronephrosis in newborn rats. VI. Long-term effects on glomerular filtration and distribution. J Urol. 1985. 134:391–395.

19. Josephson S, Robertson B, Claesson G, Wikstad I. Experimental obstructive hydronephrosis in newborn rats. I. Surgical technique and long-term morphologic effects. Invest Urol. 1980. 17:478–483.

20. Josephson S, Wolgast M, Ojteg G. Experimental obstructive hydronephrosis in newborn rats. II. Long-term effects on renal blood flow distribution. Scand J Urol Nephrol. 1982. 16:179–185.

21. Koff SA. Pathophysiology of ureteropelvic junction obstruction. Clinical and experimental observations. Urol Clin North Am. 1990. 17:263–272.

22. Koff SA, Hayden LJ, Cirulli C, Shore R. Pathophysiology of ureteropelvic junction obstruction: experimental and clinical observations. J Urol. 1986. 136:336–338.

23. Steinhardt GF, Ramon G, Salinas-Madrigal L. Glomerulosclerosis in obstructive uropathy. J Urol. 1988. 140:1316–1318.

24. Ekinci S, Ciftci AO, Atilla P, Muftuoglu S, Senocak ME, Buyukpamukcu N. Ureteropelvic junction obstruction causes histologic alterations in contralateral kidney. J Pediatr Surg. 2003. 38:1650–1655.

25. Chiou YY, Shieh CC, Cheng HL, Tang MJ. Intrinsic expression of Th2 cytokines in urothelium of congenital ureteropelvic junction obstruction. Kidney Int. 2005. 67:638–646.

26. Schreiner GF, Harris KP, Purkerson ML, Klahr S. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int. 1988. 34:487–493.

27. Yarger WE, Schocken DD, Harris RH. Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. J Clin Invest. 1980. 65:400–412.

28. Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int. 1996. 49:1110–1119.

29. Pimentel JL Jr, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M. Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int. 1995. 48:1233–1246.

30. Tataranni G, Farinelli R, Zavagli G, Logallo G, Farinelli A. Tubule recovery after obstructive nephropathy relief: the value of enzymuria and microproteinuria. J Urol. 1987. 138:24–27.

31. Zanardo V, Da Riol R, Faggian D, Plebani M, Largajolli G, Zacchello G. Urinary beta-2-microglobulin excretion in prematures with respiratory distress syndrome. Child Nephrol Urol. 1990. 10:135–138.

32. Huland H, Gonnermann D, Werner B, Possin U. A new test to predict reversibility of hydronephrotic atrophy after stable partial unilateral ureteral obstruction. J Urol. 1988. 140:1591–1594.

33. Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol. 1993. 23:478–480.

34. Dejter SW Jr, Gibbons MD. The fate of infant kidneys with fetal hydronephrosis but initially normal postnatal sonography. J Urol. 1989. 142:661–662.

35. Mearini L, Rosi P, Zucchi A, Del Zingaro M, Mearini E, Costantini E. Color Doppler ultrasonography in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction. J Endourol. 2003. 17:745–750.

36. Kincaid W, Hollman AS, Azmy AF. Doppler ultrasound in pelviureteric junction obstruction in infants and children. J Pediatr Surg. 1994. 29:765–768.

37. Kass EJ, Fink-Bennett D. Contemporary techniques for the radioisotopic evaluation of the dilated urinary tract. Urol Clin North Am. 1990. 17:273–289.

38. Heyman S, Duckett JW. The extraction factor: an estimate of single kidney function in children during routine radionuclide renography with 99mtechnetium diethylenetriaminepentaacetic acid. J Urol. 1988. 140:780–783.

39. Roarke MC, Sandler CM. Provocative imaging. Diuretic renography. Urol Clin North Am. 1998. 25:227–249.

40. Koff SA, Binkovitz L, Coley B, Jayanthi VR. Renal pelvis volume during diuresis in children with hydronephrosis: implications for diagnosing obstruction with diuretic renography. J Urol. 2005. 174:303–307.

41. Conway JJ, Maizels M. The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council--The Society of Nuclear Medicine. J Nucl Med. 1992. 33:2047–2051.

42. Capolicchio G, Jednak R, Dinh L, Salle JL, Brzezinski A, Houle AM. Supranormal renographic differential renal function in congenital hydronephrosis: fact, not artifact. J Urol. 1999. 161:1290–1294.

43. Ham WS, Jeong HJ, Han SW, Kim JH, Kim DK. Increased nephron volume is not a cause of supranormal renographic differential renal function in patients with ureteropelvic junction obstruction. J Urol. 2004. 172:1108–1110.

44. Dejter SW Jr, Eggli DF, Gibbons MD. Delayed management of neonatal hydronephrosis. J Urol. 1988. 140:1305–1309.

45. Ulman I, Jayanthi VR, Koff SA. The long-term followup of newborns with severe unilateral hydronephrosis initially treated nonoperatively. J Urol. 2000. 164:1101–1105.

46. Koff SA, Campbell KD. The nonoperative management of unilateral neonatal hydronephrosis: natural history of poorly functioning kidneys. J Urol. 1994. 152:593–595.

47. Onen A, Jayanthi VR, Koff SA. Long-term followup of prenatally detected severe bilateral newborn hydronephrosis initially managed nonoperatively. J Urol. 2002. 168:1118–1120.

48. Koff SA, Campbell K. Nonoperative management of unilateral neonatal hydronephrosis. J Urol. 1992. 148:525–531.

49. Murphy JP, Holder TM, Ashcraft KW, Sharp RJ, Goodwin CD, Amoury RA. Ureteropelvic junction obstruction in the newborn. J Pediatr Surg. 1984. 19:642–648.

50. King LR, Coughlin PW, Bloch EC, Bowie JD, Ansong K, Hanna MK. The case for immediate pyeloplasty in the neonate with ureteropelvic junction obstruction. J Urol. 1984. 132:725–728.

51. Tapia J, Gonzalez R. Pyeloplasty improves renal function and somatic growth in children with ureteropelvic junction obstruction. J Urol. 1995. 154:218–222.

52. Glick PL, Harrison MR, Noall RA, Villa RL. Correction of congenital hydronephrosis in utero III. Early mid-trimester ureteral obstruction produces renal dysplasia. J Pediatr Surg. 1983. 18:681–687.

53. Ransley PG, Dhillon HK, Gordon I, Duffy PG, Dillon MJ, Barratt TM. The postnatal management of hydronephrosis diagnosed by prenatal ultrasound. J Urol. 1990. 144:584–587.

54. Cartwright PC, Duckett JW, Keating MA, Snyder HM 3rd, Escala J, Blyth B, et al. Managing apparent ureteropelvic junction obstruction in the newborn. J Urol. 1992. 148:1224–1228.

55. Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halpren I, et al. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol. 2006. 49:734–738.

56. Anderson JC, Hynes W. Retrocaval ureter; a case diagnosed pre-operatively and treated successfully by a plastic operation. Br J Urol. 1949. 21:209–214.

57. Streem SB. Ureteropelvic junction obstruction. Open operative intervention. Urol Clin North Am. 1998. 25:331–341.

58. Ramsay JW, Miller RA, Kellett MJ, Blackford HN, Wickham JE, Whitfield HN. Percutaneous pyelolysis: indications, complications and results. Br J Urol. 1984. 56:586–588.

59. Schuessler WW, Grune MT, Tecuanhuey LV, Preminger GM. Laparoscopic dismembered pyeloplasty. J Urol. 1993. 150:1795–1799.

60. Park SJ, Kim YS, Lee HY, Han SW. Appropriate follow-up ultrasonography interval after pyeloplasty in children with ureteropelvic junction obstruction. Korean J Urol. 2008. 49:1018–1023.

61. Park SC, Ji YH, Park YS, Kim KS. Change of hydronephrosis after pyeloplasty in children with unilateral ureteropelvic junction obstruction. Korean J Urol. 2005. 46:586–592.

62. Cockrell SN, Hendren WH. The importance of visualizing the ureter before performing a pyeloplasty. J Urol. 1990. 144:588–592.

63. Kim JW, Han SW, Choi SK. The postoperative prognosis of ureteropelvic junction obstruction according to the appearance of the ureter of preoperative retrograde pyelography. Korean J Urol. 2003. 44:550–555.

64. Kim DS, Noh JY, Jeong HJ, Kim MJ, Jeon HJ, Han SW. Elastin content of the renal pelvis and ureter determines post-pyeloplasty recovery. J Urol. 2005. 173:962–966.

65. Song C, Park H, Park S, Moon KH, Kim KS. The change in renal function in the supranormal hydronephrotic kidney after pyeloplasty. BJU Int. 2007. 99:1483–1486.